• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 5-Methylpiperidine-3-carboxylic Acid (CAS No. 1095906-16-3)

5-Methylpiperidine-3-carboxylic acid, with the chemical formula C?H??NO? and CAS number 1095906-16-3, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine family, which is well-known for its diverse biological activities and applications in drug development. The structural features of 5-Methylpiperidine-3-carboxylic acid, particularly the presence of a carboxylic acid group at the 3-position and a methyl group at the 5-position, contribute to its unique chemical properties and potential therapeutic benefits.

The synthesis and characterization of 5-Methylpiperidine-3-carboxylic acid have been extensively studied due to its role as a key intermediate in the production of various pharmacologically active molecules. The compound's ability to serve as a building block for more complex structures has made it valuable in the design of novel drugs targeting neurological disorders, infectious diseases, and other therapeutic areas. Recent advancements in synthetic methodologies have improved the efficiency and scalability of producing 5-Methylpiperidine-3-carboxylic acid, enabling researchers to explore its potential more effectively.

In recent years, 5-Methylpiperidine-3-carboxylic acid has garnered attention for its applications in the development of central nervous system (CNS) drugs. The piperidine ring's structural similarity to certain neurotransmitters makes it an attractive scaffold for modulating neuronal activity. Studies have shown that derivatives of 5-Methylpiperidine-3-carboxylic acid exhibit promising effects on neurotransmitter receptors, including serotonin and dopamine receptors, which are implicated in conditions such as depression, anxiety, and Parkinson's disease. The carboxylic acid group provides a site for further functionalization, allowing chemists to tailor the compound's properties for specific biological targets.

Moreover, 5-Methylpiperidine-3-carboxylic acid has been investigated for its role in antiviral and antibacterial therapies. The unique structural motif of piperidine derivatives has been found to interfere with viral replication mechanisms by inhibiting key enzymes or proteins involved in viral life cycles. For instance, research has demonstrated that certain analogs of 5-Methylpiperidine-3-carboxylic acid can disrupt viral protease activity, thereby preventing the assembly of new viral particles. Similarly, these derivatives have shown potential in combating bacterial infections by targeting essential bacterial enzymes or metabolic pathways.

The pharmacokinetic properties of 5-Methylpiperidine-3-carboxylic acid are also subjects of interest in drug development. The compound's solubility, stability, and metabolic fate influence its bioavailability and therapeutic efficacy. Advances in computational chemistry have enabled researchers to predict and optimize these properties using molecular modeling techniques. By understanding how 5-Methylpiperidine-3-carboxylic acid interacts with biological systems at a molecular level, scientists can design more effective drug candidates with improved pharmacokinetic profiles.

One notable application of 5-Methylpiperidine-3-carboxylic acid is in the synthesis of protease inhibitors, which are crucial in treating chronic diseases such as HIV/AIDS and hepatitis C. Proteases are enzymes that play vital roles in various biological processes, including protein degradation and viral replication. By developing inhibitors that target specific proteases, researchers can modulate these processes to achieve therapeutic effects. The piperidine scaffold in 5-Methylpiperidine-3-carboxylic acid provides a versatile platform for designing potent protease inhibitors with high selectivity and low toxicity.

Recent studies have also explored the use of 5-Methylpiperidine-3-carboxylic acid in the development of treatments for neurological disorders such as epilepsy and Alzheimer's disease. The compound's ability to modulate neurotransmitter systems suggests its potential as an anticonvulsant or cognitive enhancer. Preclinical trials have shown that certain derivatives of 5-Methylpiperidine-3-carboxylic acid can reduce seizure activity in animal models without significant side effects. Additionally, these derivatives have demonstrated neuroprotective properties by scavenging reactive oxygen species and preventing neurodegeneration.

The versatility of 5-Methylpiperidine-3-carboxylic acid extends beyond pharmaceutical applications into agrochemicals and material science. In agrochemicals, derivatives of this compound have been investigated for their potential as herbicides or fungicides due to their ability to disrupt plant growth regulators or microbial enzymes. In material science, the unique structural properties of piperidine derivatives contribute to the development of advanced polymers with enhanced mechanical strength or thermal stability.

In conclusion, 5-Methylpiperidine-3-carboxylic acid (CAS No. 1095906-16-3) is a multifaceted compound with significant implications in pharmaceutical research and industrial applications. Its structural features make it a valuable intermediate for synthesizing drugs targeting various diseases, including neurological disorders, infectious diseases, and chronic conditions. Ongoing research continues to uncover new therapeutic possibilities for this compound, highlighting its importance in modern medicinal chemistry.

• 498-95-3(piperidine-3-carboxylic acid)
• 25137-00-2((3R)-piperidine-3-carboxylic acid)
• 59045-82-8((3S)-piperidine-3-carboxylic acid)
• 876367-84-9((3R,5S)-piperidine-3,5-dicarboxylic acid)
• 262853-93-0
• 110287-84-8(3-Piperidinecarboxylic acid, 4-methyl-, trans-)
• 110287-73-5(rac-(3R,5S)-5-methylpiperidine-3-carboxylic acid)
• 60252-41-7((±)-Nipecotic Acid)
• 116140-15-9(4-methylpiperidine-3-carboxylic acid)
• 110287-69-9(rac-(3R,4R)-4-methylpiperidine-3-carboxylic acid)